After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options.

The facility upgrades in automation and data analytics will be some of Lilly's most advanced manufacturing technologies, the company says.

Indianapolis-based Eli Lilly is challenging a new federal rule that would require drug companies to include prices in TV ads.

The Indianapolis drugmaker has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro. It will cost $137.35 per vial, or $265.20 for a package of five KwikPens.

Six Indiana organizations have pitched in to buy a new high-tech microscope. The nearly $9 million machine is a cryo-electron microscope that allows scientists to examine molecules at the atomic level.

On Tuesday, the company began running TV ads for a popular diabetes drug that don't give the price but direct viewers to the website .

Lilly shares have climbed 30 percent since the beginning of the year, while the Standard & Poor's 500 index has risen slightly more than 2 percent.

Contract negotiations with cleaning companies start in two weeks.

Drug maker Eli Lilly and Co. sought a 10-year tax abatement in exchange for the company investing $159 million to boost its insulin manufacturing operations at its Indianapolis technical center.

The company expects to complete the IPO by the end of this year and divest its remaining stake in the business possibly by next year.